PHARMA-BIO SERV, INC.: 10-Q filed 2015-09-14
What PHARMA-BIO SERV, INC. reported in its quarterly report filed 2015-09-14 (fiscal Q3 2015): 33 published measures, 110 facts as tagged in accession 0001354488-15-004283.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-09-14
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001354488-15-004283 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHARMA-BIO SERV, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 23,311,987 | USD | |
| At 2014-10-31 | 23,211,084 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 1,810,306 | USD | |
| At 2014-10-31 | 2,700,323 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 21,501,681 | USD | |
| At 2014-10-31 | 20,510,761 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 14,007,856 | USD | |
| At 2015-04-30 | 14,405,483 | USD | |
| At 2014-10-31 | 15,088,070 | USD | |
| At 2014-07-31 | 13,796,618 | USD | |
| At 2014-04-30 | 12,828,589 | USD | |
| At 2013-10-31 | 12,045,923 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 453,973 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 1,101,373 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 597,060 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 1,586,771 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | -348,936 | USD | 92 |
| 2014-11-01 to 2015-07-31 | -799,311 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 1,095,684 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 1,965,114 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 33,096 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 102,279 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 106,208 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 171,820 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | -13,597 | USD | 92 |
| 2014-11-01 to 2015-07-31 | -143,538 | USD | 273 |
| 2014-05-01 to 2014-07-31 | -12,639 | USD | 92 |
| 2013-11-01 to 2014-07-31 | -33,292 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | -33,096 | USD | 92 |
| 2014-11-01 to 2015-07-31 | -102,279 | USD | 273 |
| 2014-05-01 to 2014-07-31 | -106,208 | USD | 92 |
| 2013-11-01 to 2014-07-31 | -171,820 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 20,708,177 | USD | |
| At 2014-10-31 | 19,606,817 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 23,071,400 | shares | 92 |
| 2014-11-01 to 2015-07-31 | 23,077,736 | shares | 273 |
| 2014-05-01 to 2014-07-31 | 23,049,212 | shares | 92 |
| 2013-11-01 to 2014-07-31 | 22,957,160 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 23,354,538 | shares | 92 |
| 2014-11-01 to 2015-07-31 | 23,433,467 | shares | 273 |
| 2014-05-01 to 2014-07-31 | 23,609,317 | shares | 92 |
| 2013-11-01 to 2014-07-31 | 23,715,758 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 0.02 | USD/shares | 92 |
| 2014-11-01 to 2015-07-31 | 0.048 | USD/shares | 273 |
| 2014-05-01 to 2014-07-31 | 0.026 | USD/shares | 92 |
| 2013-11-01 to 2014-07-31 | 0.069 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 0.019 | USD/shares | 92 |
| 2014-11-01 to 2015-07-31 | 0.047 | USD/shares | 273 |
| 2014-05-01 to 2014-07-31 | 0.025 | USD/shares | 92 |
| 2013-11-01 to 2014-07-31 | 0.067 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 41,135 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 112,189 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 100,391 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 356,712 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 696,648 | USD | |
| At 2014-10-31 | 869,041 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 21,000 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 107,448 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 17,100 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 51,300 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 495,322 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 1,215,758 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 698,260 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 1,945,143 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 22,595,278 | USD | |
| At 2014-10-31 | 22,324,988 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 1,752,524 | USD | |
| At 2014-10-31 | 2,625,587 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 7,680,494 | USD | |
| At 2014-10-31 | 6,385,575 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 8,212 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 127,018 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 2,280 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 2,280 | USD | 273 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 2,046,237 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 5,437,580 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 2,178,236 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 6,640,351 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 1,550,915 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 4,221,822 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 1,479,976 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 4,695,208 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 23,066,450 | shares | |
| At 2014-10-31 | 23,033,912 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | -226,592 | USD | |
| At 2014-10-31 | -135,708 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 2,477,734 | USD | |
| At 2014-10-31 | 2,204,009 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-07-31 | 20,061 | USD | |
| At 2014-10-31 | 17,055 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 495,108 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 1,213,562 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 697,451 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 1,943,483 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 434,254 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 1,010,489 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 571,779 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 1,563,678 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 90,075 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 273,725 | USD | 273 |
| 2014-05-01 to 2014-07-31 | 93,882 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 281,387 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | -214 | USD | 92 |
| 2014-11-01 to 2015-07-31 | -2,196 | USD | 273 |
| 2014-05-01 to 2014-07-31 | -809 | USD | 92 |
| 2013-11-01 to 2014-07-31 | -1,660 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-05-01 to 2015-07-31 | 578,601 | USD | 92 |
| 2014-11-01 to 2015-07-31 | 1,314,222 | USD | 273 |
| 2014-05-01 to 2014-07-31 | -631,762 | USD | 92 |
| 2013-11-01 to 2014-07-31 | -1,038,841 | USD | 273 |
Inspect the source
- Entity
- PHARMA-BIO SERV, INC. / CIK 0001304161
- Captured
- 2026-09-19T11:17:27.241Z
- SEC response SHA-256
bc9f33e072a9daa74aa0e8c41fbfef83d107920bc25647db80386f28787f2d49
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001304161.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))